Ghent University Academic Bibliography

Advanced

Application of small molecules favoring naive pluripotency during human embryonic stem cell derivation

Margot Van der Jeught UGent, Jasin Taelman UGent, Galbha Duggal, Sabitri Ghimire, Sylvie Lierman, Susana Marina Chuva de Sousa Lopes UGent, Dieter Deforce UGent, Tom Deroo, Petra De Sutter UGent and Björn Heindryckx UGent (2015) CELLULAR REPROGRAMMING. 17(3). p.170-180
abstract
In mice, inhibition of both the fibroblast growth factor (FGF) mitogen-activated protein kinase kinase/extracellular-signal regulated kinase (MEK/Erk) and the Wnt signaling inhibitor glycogen synthase-3 (GSK3) enables the derivation of mouse embryonic stem cells (mESCs) from nonpermissive strains in the presence of leukemia inhibitory factor (LIF). Whereas mESCs are in an uncommitted naive state, human embryonic stem cells (hESCs) represent a more advanced state, denoted as primed pluripotency. This burdens hESCs with a series of characteristics, which, in contrast to naive ESCs, makes them not ideal for key applications such as cell-based clinical therapies and human disease modeling. In this study, different small molecule combinations were applied during human ESC derivation. Hereby, we aimed to sustain the naive pluripotent state, by interfering with various key signaling pathways. First, we tested several combinations on existing, 2i (PD0325901 and CHIR99021)-derived mESCs. All combinations were shown to be equally adequate to sustain the expression of naive pluripotency markers. Second, these conditions were tested during hESC derivation. Overall, the best results were observed in the presence of medium supplemented with 2i, LIF, and the noncanonical Wnt signaling agonist Wnt5A, alone and combined with epinephrine. In these conditions, outgrowths repeatedly showed an ESC progenitor-like morphology, starting from day 3. Culturing these "progenitor cells" did not result in stable, naive hESC lines in the current conditions. Although Wnt5A could not promote naive hESC derivation, we found that it was sustaining the conversion of established hESCs toward a more naive state. Future work should aim to distinct the effects of the various culture formulations, including our Wnt5A-supplemented medium, reported to promote stable naive pluripotency in hESCs.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
HIPPO, LINES, DIFFERENTIATION, EPIBLAST, MOUSE EMBRYOS, SELF-RENEWAL, GROUND-STATE PLURIPOTENCY, MASS, MAINTENANCE, INHIBITORS
journal title
CELLULAR REPROGRAMMING
Cell. Reprogramm.
volume
17
issue
3
pages
170 - 180
Web of Science type
Article
Web of Science id
000363927300003
JCR category
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
JCR impact factor
1.462 (2015)
JCR rank
116/161 (2015)
JCR quartile
3 (2015)
ISSN
2152-4971
DOI
10.1089/cell.2014.0085
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
7000668
handle
http://hdl.handle.net/1854/LU-7000668
date created
2015-12-03 13:06:52
date last changed
2016-12-19 15:41:57
@article{7000668,
  abstract     = {In mice, inhibition of both the fibroblast growth factor (FGF) mitogen-activated protein kinase kinase/extracellular-signal regulated kinase (MEK/Erk) and the Wnt signaling inhibitor glycogen synthase-3 (GSK3) enables the derivation of mouse embryonic stem cells (mESCs) from nonpermissive strains in the presence of leukemia inhibitory factor (LIF). Whereas mESCs are in an uncommitted naive state, human embryonic stem cells (hESCs) represent a more advanced state, denoted as primed pluripotency. This burdens hESCs with a series of characteristics, which, in contrast to naive ESCs, makes them not ideal for key applications such as cell-based clinical therapies and human disease modeling. In this study, different small molecule combinations were applied during human ESC derivation. Hereby, we aimed to sustain the naive pluripotent state, by interfering with various key signaling pathways. First, we tested several combinations on existing, 2i (PD0325901 and CHIR99021)-derived mESCs. All combinations were shown to be equally adequate to sustain the expression of naive pluripotency markers. Second, these conditions were tested during hESC derivation. Overall, the best results were observed in the presence of medium supplemented with 2i, LIF, and the noncanonical Wnt signaling agonist Wnt5A, alone and combined with epinephrine. In these conditions, outgrowths repeatedly showed an ESC progenitor-like morphology, starting from day 3. Culturing these {\textacutedbl}progenitor cells{\textacutedbl} did not result in stable, naive hESC lines in the current conditions. Although Wnt5A could not promote naive hESC derivation, we found that it was sustaining the conversion of established hESCs toward a more naive state. Future work should aim to distinct the effects of the various culture formulations, including our Wnt5A-supplemented medium, reported to promote stable naive pluripotency in hESCs.},
  author       = {Van der Jeught, Margot and Taelman, Jasin and Duggal, Galbha and Ghimire, Sabitri and Lierman, Sylvie and Chuva de Sousa Lopes, Susana Marina and Deforce, Dieter and Deroo, Tom and De Sutter, Petra and Heindryckx, Bj{\"o}rn},
  issn         = {2152-4971},
  journal      = {CELLULAR REPROGRAMMING},
  keyword      = {HIPPO,LINES,DIFFERENTIATION,EPIBLAST,MOUSE EMBRYOS,SELF-RENEWAL,GROUND-STATE PLURIPOTENCY,MASS,MAINTENANCE,INHIBITORS},
  language     = {eng},
  number       = {3},
  pages        = {170--180},
  title        = {Application of small molecules favoring naive pluripotency during human embryonic stem cell derivation},
  url          = {http://dx.doi.org/10.1089/cell.2014.0085},
  volume       = {17},
  year         = {2015},
}

Chicago
Van der Jeught, Margot, Jasin Taelman, Galbha Duggal, Sabitri Ghimire, Sylvie Lierman, Susana Marina Chuva de Sousa Lopes, Dieter Deforce, Tom Deroo, Petra De Sutter, and Björn Heindryckx. 2015. “Application of Small Molecules Favoring Naive Pluripotency During Human Embryonic Stem Cell Derivation.” Cellular Reprogramming 17 (3): 170–180.
APA
Van der Jeught, M., Taelman, J., Duggal, G., Ghimire, S., Lierman, S., Chuva de Sousa Lopes, S. M., Deforce, D., et al. (2015). Application of small molecules favoring naive pluripotency during human embryonic stem cell derivation. CELLULAR REPROGRAMMING, 17(3), 170–180.
Vancouver
1.
Van der Jeught M, Taelman J, Duggal G, Ghimire S, Lierman S, Chuva de Sousa Lopes SM, et al. Application of small molecules favoring naive pluripotency during human embryonic stem cell derivation. CELLULAR REPROGRAMMING. 2015;17(3):170–80.
MLA
Van der Jeught, Margot, Jasin Taelman, Galbha Duggal, et al. “Application of Small Molecules Favoring Naive Pluripotency During Human Embryonic Stem Cell Derivation.” CELLULAR REPROGRAMMING 17.3 (2015): 170–180. Print.